Skip to content

efficacy of Dexmedetomidine and metoral on reducing hemorrhage during craniotomy

Comparison of the effect of Dexmedetomidine and Metoprolol on reducing intraoperative bleeding in patients with craniotomy candidate due to head trauma

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190417043302N1
Enrollment
66
Registered
2019-05-12
Start date
2018-05-13
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniotomy. Traumatic amputation of other parts of head

Interventions

Intervention 1: Intervention group: Intervention group 1:We inject 1 micro gram in kilogram Dexmedetomidine in loading dose ? and 0.5 micro gram in kilogram Dexmedetomidine in hours in Infusion. Inter

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with head trauma Patients with ASA class I and II Patients that the informed written consent form has been fillede out by their legal gurdian in order to participate in the study Candidates of craniotomy due to severe head trauma Patients with severe head trauma candidates of craniotomy with a maximum operation duration of 150 min Patients with severe head trauma candidates of craniotomy that are operated by a neurosurgeon Patients with severe head trauma candidates of craniotomy aged between 15-75 years

Exclusion criteria

Exclusion criteria: Patients with severe head trauma candidates of craniotomy which have hypersensitivy to dexmedetomidine and metoprolol Patients with severe head trauma candidates of craniotomy that their legal gurdian refuse the informed written consent for participation in the study. Patients with a past medical history of cardio-vascvular diseases, uncontrolled diabetes, seizure and epilepsy, renal failure, liver failure, coagulation disorders, previous cerebrovascular accident or recent myocardial infarction

Design outcomes

Primary

MeasureTime frame
Bleeding. Timepoint: Every 15 minutes to end of surgery. Method of measurement: Observation.;Mortality. Timepoint: After surgery. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026